Xilio Therapeutics develops masked immunotherapy treatments that activate inside tumors to treat cancer. It last closed at $7.56 on Nov 20, up 0.67% on the day. The next earnings report for XLO is expected around Mon, Mar 22, 2027. For the quarter ended Sep 2026, XLO reported EPS of -$0.30 on revenue of $10.0M, with revenue down 47.6% from a year ago. Over its last 8 reports the stock moved an average of 3.5% the session after earnings. Over the last 12 months XLO insiders bought $44K of stock on the open market and sold $6K, according to SEC Form 4 filings.
AI Auto Pilots
Is XLO in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold XLO.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on XLOStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
XLO · as of the Nov 20 close · updated each morning
Downtrend, nearing oversold
The stock is 7% below its 20 day and 13% below its 50 day average. It is 12% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 38), near oversold. The nearest support is the swing low (Jun 5) at $7.53, and the nearest resistance the Pivot R1 at $7.75.
Short trendBearish
Long trendBearish
MomentumWeak
StretchNear oversold
VolatilityHigh, 7.9%/day
Key levels
$11.2052 week high+48.1%
$8.81100 day average+16.5%
$8.5650 day average+13.2%
$8.48200 day average+12.2%
$8.33Swing high (Jun 8)+10.2%
$8.0920 day average+7.0%
$7.75Pivot R1+2.5%
$7.56Last close
$7.53Swing low (Jun 5)−0.4%
$7.41Pivot−2.0%
$7.22Pivot S1−4.5%
$6.4752 week low−14.4%
Indicators
RSI (14)
37.86
Weak, oversold below 30
Neutral
MACD
-0.25
Below its signal line
Bearish
Stochastic
25.6
Middle of its range
Neutral
ADX (14)
29.9
Trending down
Williams %R
-74.4
Oversold below −80, overbought above −20
Neutral
CCI (20)
-108.5
Oversold below −100, overbought above 100
Oversold
Rate of change
−12.3%
Change over 10 sessions
Bearish
ATR (14)
$0.60
Typical daily range, 7.9% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Downtrend
Short trendBearish
Long trendBearish
MomentumWeak
StretchNormal
VolatilityLow, 13.4%/day
Key levels
$11.2052 week high+48.1%
$8.81100 day average+16.5%
$8.5650 day average+13.2%
$8.48200 day average+12.2%
$8.33Swing high (Jun 8)+10.2%
$8.0920 day average+7.0%
$7.75Pivot R1+2.5%
$7.56Last close
$7.53Swing low (Jun 5)−0.4%
$7.41Pivot−2.0%
$7.22Pivot S1−4.5%
$6.4752 week low−14.4%
Indicators
RSI (14)
38.35
Weak, oversold below 30
Neutral
MACD
-0.21
Below its signal line
Bearish
Stochastic
36.3
Middle of its range
Neutral
ADX (14)
14.5
No clear trend
Williams %R
-82.1
Oversold below −80, overbought above −20
Oversold
CCI (20)
-187.7
Oversold below −100, overbought above 100
Oversold
Rate of change
−15.3%
Change over 10 sessions
Bearish
ATR (14)
$1.01
Typical daily range, 13.4% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for XLO
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how XLO did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow XLO usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for XLOHow many large options trades hit XLO, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in XLO in the last 90 days.
From SEC Form 4 filings by XLO's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether XLO is in one of them and how their past XLO trades turned out.
Xilio Therapeutics is a biotechnology company that discovers and develops cancer immunotherapies designed to stay inactive until they reach tumors. Enzymes found in tumors remove the mask, which aims to limit activity in healthy tissue. Its pipeline includes a masked IL-2 fusion protein and masked T cell engagers, and it has partnerships with AbbVie and Gilead. The company is based in Waltham, Massachusetts, and is developing its treatments for patients with cancer.